Topiramate therapy for paroxysmal kinesigenic choreoathetosis

Movement Disorders

Volumn 20, Issue 1, 2005, Pages 75-77

  Huang, Yuan Gui ^a   Chen, Yun Chun ^a   Du, Fang ^a   Li, Rui ^a   Xu, Ge Lin ^a   Jiang, Wen ^a   Huang, Jing ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Hua Shan Centre Hospital   (China)

Author keywords

Paroxysmal kinesigenic choreoathetosis; Topiramate; Treatment

Indexed keywords

TOPIRAMATE;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT DISORDER; CHILD; CHOREOATHETOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; MENTAL DEFICIENCY; MONOTHERAPY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; ATHETOSIS; CHILD; CHOREA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; TREATMENT OUTCOME;

EID: 14044272192     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20283     Document Type: Article

References (6)

1. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571-579.
2. Fahn S. Movement disorders. In: Engel J, Pedley TA Jr, editors. Epilepsy, a comprehensive textbook. Philadelphia: Lippincott Raven Publishers; 1998. p 2725-2738.
3. Garnett WR. Clinical pharmacology of topiramate: a review. Epilepsia 2000;41(Suppl. 1):S61-S65.
4. Shirane S, Sasaki M, Kogure D, Matsuda H, Hashimoto T. Increased ictal perfusion of the thalamus in paroxysmal kinesigenic dyskinesia. J Neurol Neurosurg Psychiatry 2001;71:408-410.
5. Singh R, Macdonell RA, Scheffer IE, Crossland KM, Berkovic SF. Epilepsy and paroxysmal movement disorders in families: evidence for shared mechanisms. Epileptic Disord 1999;1:93-99.
6. Pereira AC, Loo WJ, Bamford M, Wroe SJ. Use of lamotrigine to treat paroxysmal kinesigenic choreoathetosis. J Neurol Neurosurg Psychiatry 2000;68:796-797.